We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
+2.82%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$460M
AUM Growth
-$19.1M
Cap. Flow
-$3.4M
Cap. Flow %
-0.74%
Top 10 Hldgs %
71.83%
Holding
94
New
1
Increased
7
Reduced
8
Closed
8

Top Buys

Rank Stock Value
1
MIST icon
Milestone Pharmaceuticals
MIST
+$4.28M
2
MRNS
Marinus Pharmaceuticals, Inc
MRNS
+$2.7M
3
CUE icon
Cue Biopharma
CUE
+$934K
4
OPTN
OptiNose
OPTN
+$666K
5
GPGI
GPGI Inc
GPGI
+$281K

Top Sells

Rank Stock Value
1
TCDA
Tricida, Inc. Common Stock
TCDA
+$5.24M
2
LIN icon
Linde
LIN
+$3.76M
3
HCAR
Healthcare Services Acquisition Corporation Class A Common Stock
HCAR
+$1.49M
4
CELC icon
Celcuity
CELC
+$502K
5
BKTI icon
BK Technologies
BKTI
+$481K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 19.02%
2 Healthcare 18.61%
3 Miscellaneous 17.76%
4 Industrials 15.02%
5 Financials 13.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GLD icon
1
SPDR Gold Trust
GLD
$149B
$80.6M 17.51%
475,000
– –
BC icon
2
Brunswick
BC
$4.97B
$70.3M 15.28%
975,636
– –
LIN icon
3
Linde
LIN
$226B
$38M 8.26%
116,564
-12,000
-9% -$3.76M
IVAC
4
DELISTED
Intevac Inc
IVAC
$32M 6.95%
4,944,105
– –
CTIC
5
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$23.4M 5.09%
3,893,730
-50,000
-1% -$273K
PACX
6
DELISTED
Pioneer Merger Corp. Class A Ordinary Share
PACX
$21.5M 4.68%
2,125,000
– –
INVE icon
7
Identive
INVE
$66.9M
$19.1M 4.15%
2,634,495
– –
THO icon
8
Thor Industries
THO
$4.01B
$17.2M 3.73%
227,500
– –
GPGI
9
GPGI Inc
GPGI
$3.84B
$14.7M 3.19%
3,599,298
+67,552
+2% +$281K
PROK icon
10
ProKidney
PROK
$382M
$13.7M 2.98%
2,000,000
– –
SPGI icon
11
S&P Global
SPGI
$131B
$13.4M 2.91%
40,000
– –
CORS
12
DELISTED
Corsair Partnering Corporation
CORS
$12.5M 2.72%
1,250,000
– –
MDXH icon
13
MDxHealth
MDXH
$68.8M
$11.6M 2.53%
1,958,333
– –
LSXMK
14
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$9.25M 2.01%
305,187
– –
DRRX
15
DELISTED
DURECT Corp
DRRX
$9.14M 1.99%
2,641,463
-3
-0% -$14
OPTN
16
DELISTED
OptiNose
OPTN
$7.48M 1.63%
269,675
+17,543
+7% +$666K
MRNS
17
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$7.45M 1.62%
1,872,463
+550,000
+42% +$2.7M
BX icon
18
Blackstone
BX
$107B
$5.94M 1.29%
80,000
– –
MIST icon
19
Milestone Pharmaceuticals
MIST
$144M
$5.25M 1.14%
1,326,085
+813,585
+159% +$4.28M
TV icon
20
Televisa
TV
$1.45B
$4.56M 0.99%
1,000,000
– –
IDN icon
21
Intellicheck
IDN
$57.6M
$4.15M 0.9%
2,073,583
– –
LSXMA
22
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$4.07M 0.89%
141,002
– –
AENT icon
23
Alliance Entertainment
AENT
$280M
$4.07M 0.89%
400,000
– –
JPM icon
24
JPMorgan Chase
JPM
$951B
$4.02M 0.87%
30,000
– –
AXP icon
25
American Express
AXP
$225B
$3.69M 0.8%
25,000
– –
1
2 3 4

Similar funds

NFW
Noble Family Wealth Clearwater, Florida $559M AUM 24.35% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $559M AUM 21.55% 1-Year Est. Return
SCM
Soros Capital Management New York $559M AUM 171.77% 1-Year Est. Return
PHC
Palidye Holdings (Caymans) Grand Cayman, Cayman Islands $559M AUM 1.08% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
BCM
Brasada Capital Management Houston, Texas $558M AUM 21.68% 1-Year Est. Return
FAM
Frontier Asset Management Sheridan, Wyoming $558M AUM 22.41% 1-Year Est. Return
WDG
Wealth Dimensions Group Cincinnati, Ohio $558M AUM 20.63% 1-Year Est. Return

Bleichroeder LP's Q4 2022 Portfolio in Review

As of Q4 2022, Bleichroeder LP held 94 positions worth $460M, down 4% from $479M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Bleichroeder LP's Q4 2022 filing shows 1 new, 7 increased, 8 reduced and 8 closed positions. Its largest new stake was Xperi: 34 shares worth $293. The largest sale was Tricida, Inc. Common Stock, an estimated $5.24M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Miscellaneous.

  • Bleichroeder LP's largest Q4 2022 buy was Xperi: 34 shares worth $293.
  • Bleichroeder LP added most to Milestone Pharmaceuticals in Q4 2022, an estimated $4.28M increase.
  • Bleichroeder LP's biggest Q4 2022 reduction was Linde, cutting an estimated $3.76M.
  • Bleichroeder LP fully exited Tricida, Inc. Common Stock in Q4 2022, selling an estimated $5.24M.
  • Bleichroeder LP's ten largest holdings make up 72% of its $460M portfolio in Q4 2022.
  • Bleichroeder LP opened 1 new position and closed 8 in Q4 2022.
  • Bleichroeder LP's portfolio value fell 4% quarter-over-quarter to $460M.

Based on Bleichroeder LP's 13F filing for Q4 2022, filed 14 Feb 2023.